Related Experiment Video

Updated: Jun 4, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

mTOR links oncogenic signaling to tumor cell metabolism

Jessica L Yecies1, Brendan D Manning

  • 1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.

Journal of Molecular Medicine (Berlin, Germany)
|February 9, 2011
PubMed

Insights

The mammalian target of rapamycin (mTOR) complex 1 (mTORC1) pathway regulates cell growth and metabolism. Aberrant mTORC1 activation drives cancer by promoting anabolic processes like glucose uptake and lipid synthesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Metabolism

Background:

  • The mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is a critical regulator of cell growth and proliferation.
  • Aberrant mTORC1 activation, driven by oncogenes and tumor suppressors, is common in human cancers.
  • While upstream signaling is well-studied, downstream molecular events driving tumor growth are emerging.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which mTORC1 regulates cellular metabolism.
  • To explore the consequences of mTORC1-mediated metabolic reprogramming for tumor growth.
  • To identify potential therapeutic strategies targeting mTORC1's metabolic functions.

Main Methods:

  • Focus on molecular mechanisms of mTORC1-driven metabolic regulation.
  • Review of recent studies on mTORC1's role in metabolic pathways.
  • Analysis of consequences for cancer cell proliferation and therapeutic interventions.

Main Results:

  • mTORC1 activation promotes key metabolic pathways essential for cancer.
  • These include increased glucose uptake, glycolysis, and de novo lipid biosynthesis.
  • mTORC1 also regulates the pentose phosphate pathway, supporting anabolic growth.

Conclusions:

  • mTORC1 is a central regulator of cancer cell metabolism, fueling anabolic growth.
  • Understanding these downstream metabolic effects is crucial for developing targeted cancer therapies.
  • Targeting mTORC1-mediated metabolic reprogramming offers promising therapeutic avenues.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...